FDA Inspection 1318108 — Daiichi Sankyo, Inc.
The FDA completed an inspection of Daiichi Sankyo, Inc. on May 4, 2026 in Basking Ridge, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 4, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Basking Ridge, NJ (United States)
Additional Details
Sponsor, Contract Research Organization